hydroxychloroquine has been researched along with trimethoprim, sulfamethoxazole drug combination in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Aydintuğ, OT; Batioğlu, F; Heper, AO; Ozmert, E; Taner, P | 1 |
| Aramendi, JI; Blanco, MJ; Boado, MV; Gaafar, A; Goikoetxea, J; Marín, M; Montejo, M; Mularoni, A | 1 |
| Lagier, JC; Lochouarn, M; Pulcini, C; Raoult, D | 1 |
| Cikirikcioglu, M; Emonet, S; Harbarth, S; Lagier, JC; Raoult, D; Schrenzel, J; van Delden, C; Wassilew, N; Wuillemin, T | 1 |
| Alfaro-Lozano, JL; Elera-Fitzcarrald, C; Pastor-Asurza, CA | 1 |
| Bulanov, NM; Moiseev, SV; Novikov, PI; Zykova, AS | 1 |
| Jayne, D; Kronbichler, A | 1 |
| Shimada, K; Sugii, S; Takamasu, E; Yokogawa, N | 1 |
| Alcobendas, R; Álvarez-Rojas, E; de la Serna, O; Laplaza-González, M; Murias, S; Quintana-Ortega, C; Remesal, A; Ruiz de Valbuena, M; Udaondo, C | 1 |
9 other study(ies) available for hydroxychloroquine and trimethoprim, sulfamethoxazole drug combination
| Article | Year |
|---|---|
Recurrent optic disc and retinal vasculitis in a patient with drug-induced urticarial vasculitis.
Topics: Anti-Infective Agents; Dermatologic Agents; Drug Industry; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Methylprednisolone; Middle Aged; Optic Disk; Pulse Therapy, Drug; Recurrence; Retinal Vasculitis; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Urticaria; Vasculitis, Leukocytoclastic, Cutaneous | 2006 |
[Tropheryma wipplei endocarditis: a report of 3 cases].
Topics: Actinomycetales Infections; Anti-Bacterial Agents; Anticoagulants; Doxycycline; Drug Therapy, Combination; Edema, Cardiac; Endocarditis, Bacterial; Fever; Heart Valve Diseases; Humans; Hydroxychloroquine; Male; Middle Aged; Polymerase Chain Reaction; Shock, Cardiogenic; Stroke; Trimethoprim, Sulfamethoxazole Drug Combination; Tropheryma | 2013 |
A case of Whipple's disease evolving over 30 years.
Topics: Anti-Bacterial Agents; Antibodies, Bacterial; Aortic Valve Insufficiency; Biopsy; Disease Progression; Doxycycline; Duodenum; Follow-Up Studies; Heart Valve Prosthesis Implantation; Humans; Hydroxychloroquine; Hypertension, Pulmonary; Immunoenzyme Techniques; Lymph Nodes; Male; Medication Adherence; Middle Aged; Pericarditis, Constrictive; Recurrence; Trimethoprim, Sulfamethoxazole Drug Combination; Tropheryma; Whipple Disease | 2014 |
Relapse of Tropheryma whipplei endocarditis treated by trimethoprim/sulfamethoxazole, cured by hydroxychloroquine plus doxycycline.
Topics: Anti-Bacterial Agents; Aortic Valve; Ceftriaxone; Doxycycline; Drug Therapy, Combination; Endocarditis, Bacterial; Heart Valve Diseases; Humans; Hydroxychloroquine; Male; Middle Aged; Recurrence; Trimethoprim, Sulfamethoxazole Drug Combination; Tropheryma; Whipple Disease | 2015 |
Garre's sclerosing osteomyelitis caused by salmonella group D in a patient with systemic lupus erythematosus: an unusual complication.
Topics: Adult; Anti-Bacterial Agents; Antiphospholipid Syndrome; Ceftazidime; Doxycycline; Femur; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Male; Methotrexate; Osteomyelitis; Prednisone; Salmonella Infections; Sclerosis; Trimethoprim, Sulfamethoxazole Drug Combination | 2015 |
Prevention of infections in patients with antineutrophil cytoplasm antibody-associated vasculitis: potential role of hydroxychloroquine.
Topics: Antibodies, Antineutrophil Cytoplasmic; Cytoplasm; Humans; Hydroxychloroquine; Infections; Rituximab; Trimethoprim, Sulfamethoxazole Drug Combination | 2020 |
Response to: 'Prevention of infections in patients with antineutrophil cytoplasm antibody-associated vasculitis: potential role of hydroxychloroquine' by Novikov
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Cytoplasm; Humans; Hydroxychloroquine; Infections; Rituximab; Trimethoprim, Sulfamethoxazole Drug Combination | 2020 |
Simple dose-escalation regimen for hydroxychloroquine-induced hypersensitivity reaction in patients with systemic lupus erythematosus enabled treatment resumption.
Topics: Adult; Anti-Bacterial Agents; Antirheumatic Agents; Clinical Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Hypersensitivity; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Japan; Lupus Erythematosus, Systemic; Male; Middle Aged; Prednisolone; Retrospective Studies; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2019 |
Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report.
Topics: Adenosine Monophosphate; Alanine; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; Autoantibodies; Bronchoscopy; Child; COVID-19; COVID-19 Nucleic Acid Testing; Cyclophosphamide; Dermatomyositis; Disease Progression; Fatal Outcome; Female; Humans; Hydroxychloroquine; Immunocompromised Host; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Interferon-Induced Helicase, IFIH1; Lung; Lung Diseases, Interstitial; Lymphohistiocytosis, Hemophagocytic; Mediastinal Emphysema; Methylprednisolone; Piperidines; Pneumonia, Pneumocystis; Pneumothorax; Pyrimidines; Respiratory Insufficiency; Shock, Septic; Subcutaneous Emphysema; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination | 2021 |